Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$129.91 - $234.98 $282,943 - $511,786
-2,178 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$109.18 - $185.98 $55,463 - $94,477
-508 Reduced 18.91%
2,178 $350,000
Q4 2020

Jan 13, 2021

SELL
$65.74 - $169.86 $6,836 - $17,665
-104 Reduced 3.73%
2,686 $281,000
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $35,592 - $62,126
655 Added 30.68%
2,790 $197,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $1,453 - $3,920
49 Added 2.35%
2,135 $137,000
Q1 2020

May 12, 2020

SELL
$17.78 - $31.58 $26,065 - $46,296
-1,466 Reduced 41.27%
2,086 $62,000
Q4 2019

Feb 07, 2020

BUY
$13.93 - $21.28 $49,479 - $75,586
3,552 New
3,552 $69,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.